Obesity: A Multimodal Disease Requiring Ongoing Innovation
Obesity is a complex disease affecting nearly every organ system and is associated with various diseases like hypertension, type 2 diabetes, and cardiovascular risk. Metabolic and bariatric surgery (MBS) has become the most effective long-term treatment for severe obesity, significantly improving both weight loss and related health conditions. This editorial questions whether surgical innovations in MBS are aimed at benefiting patients or merely appealing to surgeons.
From Open Surgery to the Laparoscopic Revolution
The late twentieth century saw a shift from open surgery to laparoscopy in MBS, notably reducing operative morbidity. Studies showed lower perioperative risks with laparoscopic procedures, including fewer complications and shorter hospital stays, with no compromise in weight loss outcomes. By the early 2000 s, laparoscopy became the gold standard in MBS, highlighting that appropriate technological innovations can reduce risk while maintaining efficacy. The ongoing evolution in surgical techniques prompts a pivotal question: Are these innovations primarily serving the patient’s well-being, or are they sometimes driven more by the surgeon’s fascination with technology?